At Novotech, we are dedicated to fostering a diverse, equitable and inclusive workplace where all employees, regardless of gender, feel valued, respected and supported.
A key focus of our diversity and inclusion efforts is achieving greater gender balance across all levels of our organisation. To that end, we have set clear goals and targets aimed at maintaining gender parity in leadership roles, ensuring equal access to career development opportunities, and eliminating any existing pay gaps between men and women.
"At Novotech, we firmly believe in diversity, inclusion and gender equality," said Dr. John Moller, CEO of Novotech Holdings. "Our certification by WGEA as a leading Employer of Choice for Gender Equality underscores our progress, but we have further work to do. I am fully committed to achieving equal pay, eliminating our gender pay gap worldwide, and maintaining zero tolerance for harassment and discrimination. We will continue expanding our diversity and inclusion efforts globally, as we know that equality strengthens our organisation, drives innovation and enhances our ability to serve customers."
On October 19, 2023, Novotech hosted a panel discussion titled "Tackling Gender Disparities in the Life Sciences" featuring both internal and external leaders. The event was moderated by our CEO Dr. John Moller, and reinforced our commitment to gender equality and highlighted the importance of achieving parity in an industry where women are underrepresented, especially in senior roles.
Our strategy emphasises leadership accountability, transparent compensation practices, work-life balance policies, zero tolerance for discrimination and harassment, regular data collection and reporting, and continuous evaluation and improvement of our gender equality initiatives.
We're proud to drive positive change as we create an approachable workplace where everyone's talents help us innovate, serve customers, and succeed. By embracing all our people, we can make great strides that benefit employees, clients, and communities.
Defining Gender Gaps
Introducing Gender Diversity from Entry Roles
Quality Processes
Reducing Gender Pay Gap
Tackling Gender Disparities
Media contact
Toyna Chin
About Novotech Novotech-CRO.com
Novotech is a globally recognized full-service clinical research organization (CRO) and scientific advisory company trusted by biotech and small- to mid-sized pharmaceutical companies to guide drug development at every phase.
With a global footprint that includes 30+ offices across the Asia-Pacific region, North America, and Europe and partnerships with 5,000+ trial sites, Novotech provides clients an accelerated path to bring life-changing therapies to market by providing access to key clinical trial destinations and diverse patient populations.
Through its client-centric service model, Novotech seamlessly integrates people, processes, and technologies to deliver customized solutions that accelerate the path to market for life-changing therapies. By adopting a true partnership approach, Novotech shares a steadfast commitment to client success, empowering innovation, and advancing healthcare worldwide. Recipient of numerous industry accolades, including the Frost & Sullivan CRO Company of the Year award for 19 consecutive years, Novotech is recognized for its excellence in clinical trial execution and innovation. Its deep therapeutic and regulatory expertise, combined with local market insights, ensures streamlined clinical trials, optimized data analytics, and accelerated patient recruitment strategies.
Together with clients, Novotech transforms scientific advancements into therapies that improve global health outcomes, embodying a mission of driving innovation and delivering impactful results.
For more information or to speak to an expert team member visit www.Novotech-CRO.com